David Donabedian was Appointed as Chief Executive Officer, Co founder and Director at Axial-Biotherapeutics

Date of management change: November 15, 2016 

What Happened?

Boston, MA-based Axial-Biotherapeutics Appointed David Donabedian as Chief Executive Officer, Co founder and Director

 

About the Company

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders

 

About the Person

David Donabedian is Chief Executive Officer, Co founder and Director at Axial Biotherapeutics. Previously, David held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Berglund Erika, Morczinek Ebony, Avanzato Ashley, Wheeler David, Schissler Molly, Lysford Jill, Holles Nichole, Stephens Lillian, Korn Efrat, Anderson Nick, Tandon Birage

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.